Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5
Original Research
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,067 | Dovepress* | 10,005+ | 2,398 | 12,403 | |
| PubMed Central* | 3,062 | 882 | 3,944 | ||
| Totals | 13,067 | 3,280 | 16,347 | ||
|
*Since 2 September 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar